Integer Holdings Corp (ITGR) Cash Flow Statement
A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.
Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally.
Total Cash From Operating Activities Chart for Integer Holdings Corp
Integer Holdings Corp (ITGR) operating cash flow for FY2025 was USD 196.1M, a -4.4% change from FY2024. Integer Holdings Corp's operating cash flow grew from USD 9.0M in 1999 to USD 196.1M in 2025 (2081.4% over 26 years). Operating cash flow compound annual growth rate: 5-year CAGR of 1.6%, 10-year CAGR of 31.7%, 20-year CAGR of 7.8%.
Total Cash From Operating Activities (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $4.30B
- Implied Share Price
- $126.54
- Enterprise Value
- $5.64B
- Revenue (TTM)
- $1.84B
- EBITDA
- $347.70M
- Profit Margin
- 6.97%
- Trailing P/E
- 34.57
- Forward P/E
- 22.42
- Price/Book (MRQ)
- 2.50
- Price/Sales (TTM)
- 2.33
- EV/EBITDA
- 18.39
- EV/Revenue
- 3.06
- Dividend Yield
- —
- Book Value
- $50.56
- Free Cash Flow (FY2025)
- $105.12M
- Free Cash Flow Yield
- 2.44%
Snapshot as of 24th October 2026 — not point-in-time controlled, may lag the live market by a few days.